XIAODAN ZHOU: Open Payments
NPI 1841956034 · LEWISTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 32 payments from 16 companies in 2025. Trend: 2023 $395 · 2024 $601 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| CVRx, Inc. | 2 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 4 | $61 |
| PFIZER INC. | 2 | $50 |
| Exact Sciences Corporation | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| SCPHARMACEUTICALS INC. | 2 | $36 |
Products named: VERQUVO, JARDIANCE, Barostim Neo System, LEQVIO, CAMZYOS, VYNDAQEL, Cologuard Collection Kit, ONPATTRO.
Industry payments across NY — which companies pay providers there.
